Infants given the monoclonal antibody nirsevimab (Beyfortus) to provide passive immunity against respiratory syncytial virus ...

We continue our look at contagious illnesses circulating right now with a focus on RSV, which stands for respiratory ...

ATLANTA -- Maternal respiratory syncytial virus (RSV) vaccination during pregnancy and infant RSV immunization -- either alone or combined -- appeared to be safe and effective at boosting neutralizing ...

The recent safety review of two approved RSV preventive treatments for infants initiated by the U.S. Food and Drug ...

Each winter, worried parents have flooded health care providers’ offices with sick babies, hoping for treatment that could help their infant recover from this “stubborn cold.” Many parents don’t ...

These babies experienced no ill effects from a dose of nirsevimab on top of mom’s vaccination However, those whose moms weren’t vaccinated had a greater antibody response from niresevimab MONDAY, Oct.

For the first time, U.S. infants saw dramatically fewer RSV hospitalizations thanks to new maternal vaccines and nirsevimab, highlighting the urgent need for early, widespread prevention each season.

The American Academy of Pediatrics has issued updated recommendations for RSV prevention in infants and high-risk young children.